INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 254 filers reported holding INSMED INC in Q3 2023. The put-call ratio across all filers is 6.19 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,680,968 | +19.7% | 66,573 | 0.0% | 0.11% | +113.7% |
| Q2 2023 | $1,404,690 | +23.8% | 66,573 | 0.0% | 0.05% | +96.2% |
| Q1 2023 | $1,135,070 | -34.4% | 66,573 | -23.1% | 0.03% | -13.3% |
| Q4 2022 | $1,730,308 | +167.0% | 86,602 | +187.9% | 0.03% | +172.7% |
| Q3 2022 | $648,000 | -58.2% | 30,085 | -54.4% | 0.01% | -63.3% |
| Q1 2022 | $1,550,000 | +68.5% | 65,971 | +95.3% | 0.03% | +25.0% |
| Q4 2021 | $920,000 | -6.2% | 33,786 | -5.2% | 0.02% | +33.3% |
| Q3 2021 | $981,000 | +10.0% | 35,629 | +13.6% | 0.02% | +12.5% |
| Q2 2021 | $892,000 | -13.6% | 31,358 | +3.4% | 0.02% | -11.1% |
| Q1 2021 | $1,033,000 | +64.2% | 30,320 | +60.4% | 0.02% | +63.6% |
| Q4 2020 | $629,000 | +3.6% | 18,900 | 0.0% | 0.01% | -38.9% |
| Q3 2020 | $607,000 | +23.9% | 18,900 | +6.2% | 0.02% | -21.7% |
| Q2 2020 | $490,000 | – | 17,800 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 5,889,491 | $148,709,648 | 14.07% |
| Deep Track Capital, LP | 6,000,000 | $151,500,000 | 5.85% |
| Octagon Capital Advisors LP | 1,284,000 | $32,421,000 | 4.98% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,446,334 | $87,019,934 | 4.70% |
| MPM BioImpact LLC | 527,458 | $13,318,315 | 3.56% |
| Novo Holdings A/S | 1,339,304 | $33,817,426 | 2.50% |
| Bleichroeder LP | 325,000 | $8,206,250 | 2.02% |
| GREAT POINT PARTNERS LLC | 394,872 | $9,970,518 | 1.82% |
| Endurant Capital Management LP | 79,471 | $2,006,643 | 1.80% |
| SECTORAL ASSET MANAGEMENT INC | 347,392 | $8,771,648 | 1.71% |